Randomized Trialvery high evidence

Retatrutide Once Weekly in Adults with Knee Osteoarthritis Pain and Obesity.

The New England journal of medicine·November 8, 2026·PMID 43001755

Why it matters

Painful knee osteoarthritis in patients with obesity is challenging to manage; weight loss can improve symptoms but is difficult to sustain. Retatrutide offers a novel pharmacologic approach that simultaneously addresses obesity and pain, potentially reducing the need for analgesics or joint interventions.

Infographic summary of Retatrutide Once Weekly in Adults with Knee Osteoarthritis Pain and Obesity.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled